Cyltezo: Dosage and Cost of the FDA-Approved Interchangeable Biosimilar, adalimumab-adbm to Humira® Medical advancements have revolutionized the treatment options for various diseases and conditions. In recent years, biosimilars have gained significant attention as cost-effective alternatives to biologic medications. One such biosimilar is Cyltezo, which is an interchangeable biosimilar to Humira®, a commonly used medication for…
Regeneron’s Pozelimab-BBFG Receives FDA Approval as First Treatment for CHAPLE Disease
The drug Pozelimab can cause life-threatening meningococcal infections, so it is important to get a meningococcal vaccine at least 2 weeks before starting the drug.
It is used to treat a health problem called CD55-deficient protein-losing enteropathy (CHAPLE disease).
Advising On Very Dry and Eczema-prone Skin
Emollients form the basis of dry skin management, including eczema as well as moisturizing the skin. They form a protective barrier to prevent moisture loss and keep allergens and irritants out.
Learn how to get your academic papers ready for publication.
Learn how to get your academic papers ready for publication.